Sjögren-associated myelitis

An imaging reference for spinal cord involvement, differential diagnosis, and reporting. There is no diagnostic MRI signature; attribution requires clinical and laboratory correlation.

Reference Images

Teaching graphic summarizing supplied Sjögren-associated myelitis MRI features
1. Sjögren-associated myelitis: imaging featuresSelect to enlarge
Teaching graphic comparing the supplied differential diagnoses; discordant ARIA-E header retained
2. Sjögren-associated myelitis DDX:Select to enlarge
Sagittal cervical MRI with original arrow pointing toward the cervical cord
3. Sagittal cervical MRI with source arrow. No diagnostic caption supplied.Select to enlarge
Cervical MRI with sagittal panel a and axial panel b, retaining original labels
4. Sagittal and axial cervical MRI, panels a and b. No diagnostic caption supplied.Select to enlarge
Sagittal cervical and upper thoracic MRI; supplied caption Acute Transverse Myelitis
5. Acute Transverse MyelitisSelect to enlarge

Source limitations: the second graphic has a discordant “ARIA-E” header. Images 3–4 have no supplied diagnostic captions or patient context; they are not independently established examples of Sjögren myelitis. Image 5 retains the supplied caption.

Imaging clue

Longitudinal, sometimes tract-selective T2 signal, particularly in dorsal columns or lateral tracts; this is not specific.

Attribution

Sjögren disease can coexist with AQP4-positive NMOSD. Sjögren status alone does not establish the cause of a cord lesion.

Key pitfall

A normal early MRI or absent enhancement does not exclude inflammatory disease. Posterior-column signal may also reflect sensory neuronopathy.

Focusing just on Sjögren-associated myelitis: it is a rare inflammatory spinal cord manifestation that can occur independently of NMOSD. The most useful radiologic clue is longitudinal, sometimes tract-selective T2 hyperintensity—particularly involving the dorsal columns or lateral tracts—but there is no diagnostic MRI signature. pmc.ncbi.nlm.nih

Spinal MRI findings

FeatureFindings in Sjögren-associated myelitis
LocationCervical cord involvement is well described, sometimes extending into the thoracic cord. pmc.ncbi.nlm.nih
Lesion lengthLong-segment lesions are characteristic in the small dedicated series, although broader Sjögren CNS cohorts also contain short lesions. pmc.ncbi.nlm.nih
Axial distributionDorsal-column predominant, lateral corticospinal/spinothalamic tract predominant, or central gray-matter involvement. pmc.ncbi.nlm.nih
T2 appearanceMay be relatively sharply confined to anatomically defined longitudinal tracts rather than diffusely involving the entire cord cross-section. pmc.ncbi.nlm.nih
EnhancementVariable and frequently absent; lack of enhancement does not exclude clinically significant inflammatory disease. pmc.ncbi.nlm.nih
Early examinationMRI can initially be normal, with abnormalities appearing on subsequent examinations. pmc.ncbi.nlm.nih
Associated brain findingsBrain MRI may be normal or show nonspecific punctate deep/periventricular white-matter lesions; no accompanying brain pattern establishes Sjögren myelitis. pmc.ncbi.nlm.nih

Most relevant evidence

A particularly relevant study is Butryn et al., Journal of Clinical Medicine, 2020, which described four patients with Sjögren-associated inflammatory myelitis: all were AQP4- and MOG-antibody negative, and none met NMOSD criteria. pmc.ncbi.nlm.nih

The caveat: this is a four-patient series, so tract-selective involvement is a useful consideration—not a validated discriminator or a finding specific to Sjögren disease. pmc.ncbi.nlm.nih

Radiology reporting

For a compatible lesion in someone with established Sjögren disease, reasonable wording would be:

“Longitudinally extensive, [dorsal-column/lateral-tract/central]-predominant intramedullary T2 signal abnormality, compatible with inflammatory myelitis. Sjögren-associated myelitis is a consideration given the clinical history; the imaging appearance is not specific.”

Sjögren-associated myelitis has no single diagnostic MRI pattern. In a patient with Sjögren disease and myelitis—particularly longitudinally extensive transverse myelitis (LETM)—the primary radiologic concern should be coexisting AQP4-IgG–positive neuromyelitis optica spectrum disorder (NMOSD) rather than automatically attributing the lesion to Sjögren disease itself. pmc.ncbi.nlm.nih

The report covers:

The most NMOSD-favoring findings are central LETM, cord expansion, bright spotty lesions, cervicomedullary extension, posterior/chiasmal optic neuritis, and area-postrema or AQP4-rich periependymal brain lesions. Serum AQP4-IgG testing by cell-based assay—and MOG-IgG testing if negative—is essential because Sjögren disease can coexist with NMOSD, while AQP4/MOG-negative Sjögren myelitis remains a diagnosis of exclusion. pmc.ncbi.nlm.nih

Even when focusing on Sjögren itself, the diagnosis should remain clinicoradiologic rather than imaging-only: Sjögren status does not prove the cause of a cord lesion, and AQP4/MOG-associated disease should still be excluded before assigning it directly to Sjögren disease. pmc.ncbi.nlm.nih

For suspected Sjögren-associated myelitis, the main radiologic differential includes inflammatory demyelination, metabolic or degenerative tractopathy, and vascular mimics; axial distribution and enhancement pattern are particularly helpful. pmc.ncbi.nlm.nih

Imaging differential

DiagnosisFeatures favoring it over Sjögren myelitis
AQP4-positive NMOSDCentral LETM, substantial cross-sectional involvement, cord expansion, T2 “bright spotty” lesions, cervicomedullary extension; associated posterior/chiasmal optic neuritis or area-postrema lesions. pmc.ncbi.nlm.nih
MOG antibody-associated diseaseCentral gray-matter H-sign, conus involvement, and sometimes leptomeningeal enhancement; intramedullary enhancement may be faint or absent. pmc.ncbi.nlm.nih
Multiple sclerosisMultiple short-segment, peripheral dorsal/lateral lesions, usually involving a small portion of the cord; accompanying characteristic brain lesions support MS. pmc.ncbi.nlm.nih
NeurosarcoidosisLong-segment lesion with dorsal subpial enhancement, central canal enhancement producing the axial trident sign, or associated leptomeningeal/nerve-root enhancement; enhancement may persist for months. pmc.ncbi.nlm.nih
B12 or copper deficiency; nitrous oxide–related myelopathySymmetric posterior-column ± lateral-column signal, often an axial inverted-V appearance, usually without enhancement or appreciable expansion; exposure history and laboratory testing distinguish these. pmc.ncbi.nlm.nih
Sjögren sensory neuronopathyLongitudinal posterior-column signal from secondary degeneration rather than primary myelitis; chronic atrophy, sensory ataxia, areflexia, and reduced/absent sensory nerve-action potentials support this diagnosis. pmc.ncbi.nlm.nih
Paraneoplastic myelopathyLong, tract-selective dorsal or lateral column lesions, sometimes bilateral and symmetric; tract-specific enhancement and a progressive course are important clues. pmc.ncbi.nlm.nih
Spinal dural AV fistulaLong thoracic/conus edema, serpiginous perimedullary vessels/flow voids, and variable enhancement; particularly important in a progressive myelopathy. pmc.ncbi.nlm.nih
Spinal cord infarctionHyperacute onset, diffusion restriction, anterior/central gray-matter involvement with owl’s-eye or sagittal pencil-like signal; associated vertebral-body infarction can help. pmc.ncbi.nlm.nih
Compressive/spondylotic myelopathySignal centered at or immediately below significant stenosis; transverse pancake-like enhancement favors a compressive mechanism. pmc.ncbi.nlm.nih
Infectious myelitisVariable central or longitudinal lesions; meningeal/root enhancement, immunosuppression, systemic infection, and CSF findings help distinguish viral, syphilitic, tuberculous, or other infectious causes. pmc.ncbi.nlm.nih
Intramedullary neoplasmPersistent focal masslike expansion, a discrete enhancing component, associated cyst/syrinx or hemorrhage, and progressive enlargement favor tumor over inflammatory myelitis. pmc.ncbi.nlm.nih

If dorsal-column predominant

For a long, nonexpansile, nonenhancing dorsal-column lesion, the most focused differential is B12/copper deficiency or nitrous oxide toxicity, Sjögren sensory neuronopathy, Sjögren tract-selective inflammatory myelitis, and paraneoplastic tractopathy. pmc.ncbi.nlm.nih

A posterior-column lesion in someone with Sjögren disease is not necessarily inflammatory myelitis—secondary degeneration from sensory ganglionopathy is an especially relevant alternative. jnnp.bmj

Scope limitation: the supplied text announces a recommended MRI protocol and broader brain/orbital review, but does not provide a complete protocol or detailed review. No additional protocol has been inferred.

Secondary Links